bioRxiv Science⌕ Search

bioRxiv · 10.1101/778787

Circadian regulation of muscle growth independent of locomotor activity

Abstract

Muscle tissue shows circadian variation, but whether and how the intracellular circadian clock per se regulates muscle growth remains unclear. By measuring muscle growth over 12 h periods, here we show that muscle grows more during the day than at night. Inhibition of muscle contraction reduces growth to a similar extent in day and night, but does not ablate the circadian variation in growth. Muscle protein synthesis is higher during the day compared to night, whereas markers of protein degradation are higher at night. Mechanistically, the TORC1 inhibitor rapamycin inhibits the extra daytime growth, but no effect on muscle growth at night was detected. Conversely, the proteasomal inhibitor MG132 increases muscle growth at night, but has no effect during the day, irrespective of activity. Ablation of contractile activity rapidly reduces muscle protein synthesis both during the day and at night and leads to a gradual increase in Murf gene expression without ablating circadian variation in growth. Removal of circadian input by exposure to either permanent light or permanent darkness reduces muscle growth. We conclude that circadian variation in muscle growth is independent of the presence of, or changes in, physical activity and affects both protein synthesis and degradation in distinct circadian phases.

Source connections

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Kelu, J. J., Pipalia, T., Hughes, S. M.. 2019-09-23. Circadian regulation of muscle growth independent of locomotor activity. https://doi.org/10.1101/778787

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

An LRH-1 agonist reverses hepatic metabolic dysfunction in obesity

Liver receptor homolog-1 (LRH-1; NR5A2) is a nuclear receptor that controls metabolic gene programs important for liver health. Here, we address two challenges with dissecting ligand-driven LRH-1 metabolism in vivo. First, we generate ME610, a potent LRH-1 agonist with favorable pharmacokinetic properties. Second, we engineer Nr5a2humLBD mice, edited to recapitulate the ligand response of the human receptor. ME610 dose-dependently induces LRH-1 target genes and reduces triglycerides in livers of Nr5a2humLBD mice. In a mouse model of diet-induced obesity (DIO), ME610 dramatically improves insulin sensitivity and reduces liver fat. Multi-omics integration of transcriptomics, lipidomics, and metabolomics data demonstrates a coordinated reversal of DIO-induced hepatic metabolic stress via changes in lipid, amino acid, and energy metabolism, with peroxisomal lipid metabolism emerging as a central process correlated to efficacy. These studies uncover new pathways through which LRH-1 regulates metabolism and demonstrate the therapeutic potential of synthetic LRH-1 agonists in obesity-associated metabolic diseases.

physiology↗

SCN- induces prestin contraction through reduced intermonomer angles and a modified transporter like movement of each monomer.

Prestin is the membrane based molecular motor responsible for outer hair cell electromotility that expands and contracts in response to transmembrane voltage. How voltage brings these about is unknown but cryoEM structures in the presence of ligands has led to the extrapolation of structures with the transporter cycle and its expansion contraction coupling. We find prestin to adopt novel increasingly contracted states that are brought about by a reduced intermonomer angles in the obligate dimers and a transmembrane contraction of each monomer at its cytoplasmic half in the presence of SCN-. These changes are associated with a loss in the intermonomer beta sheet at its N terminus. There is a hyperpolarizing shift in Vh along with increased affinity for SCN-. SCN- binding at the internal binding site likely cause the structural changes since they are reversed by SCN- displacement by salicylate.

physiology↗

Leg blood flow and muscle oxygenation are reduced when exercising with loads >=40% 1RM compared to loads <=30% 1RM due to increases in contraction induced intramuscular pressure

The critical occluding tension (COT) is the load at which contraction-induced increases in intramuscular pressure (IMP) collapse intramuscular vasculature and impair oxygen delivery. For knee extension resistance exercise, the COT occurs at ~30-40% 1RM, yet few studies have measured IMP alongside convective oxygen delivery. This study examined the interaction between IMP, leg blood flow, and muscle oxygenation during resistance exercise. Twelve participants completed knee extension bouts across a range of loads while vastus lateralis IMP, femoral blood flow (Doppler), blood pressure, muscle oxygenation (NIRS), and electromyography (EMG) were recorded. Mean IMP increased alongside relative load (20% 1RM=19.1(9.4) mmHg; 30% 1RM=22.4(10.4) mmHg; 40% 1RM=27.0(8.7) mmHg; 50% 1RM=31.5(11.5) mmHg; 60% 1RM=41.14(13.8) mmHg; p<0.05). Leg blood flow scaled to rest was similar between 20% and 30% 1RM (p=0.13), 40%, 50%, and 60% 1RM (p>0.05), but different between the 20-30% 1RM and 40-60% 1RM groupings (p<0.05) (20% 1RM=2.6(1.4) times rest; 30% 1RM=1.8(0.5) fold of rest; 40% 1RM=1.4(0.6) fold of rest; 50% 1RM=1.1(0.4) fold of rest; 60% 1RM=1.1(0.5) fold of rest). Muscle oxygenation was lower at 40%, 50%, and 60% 1RM compared to 20% and 30% 1RM (p<0.05). Thus, at [&le;]30% 1RM exercising blood flow increased well above rest, indicating preserved microvascular perfusion, whereas at [&ge;]40% 1RM the rise in IMP was sufficient to impair perfusion and limit blood flow increases. Exercise at or above the COT restricts convective oxygen delivery due to contraction-induced increases in IMP.

physiology↗